What's New: Drugs RSS FeedFDA approves two separate indications for fam-trastuzumab deruxtecan-nxki in HER2-positive early-stage breast cancerOncology (Cancer)/Hematologic Malignancies Approval NotificationsWhat's New Related to DrugsDrug Alerts and StatementsFDA warns consumers not to use expired Amazon Basic Care Levonorgestrel 1.5 mgCDER Leadership BiosCenter for Drug Evaluation and Research Organization ChartWithdrawn | Infectious Disease Accelerated ApprovalsAccelerated Approval ProgramOngoing | Non-malignant Hematological, Neurological, and Other Disorder Indications Accelerated Approvals[get_content_from url=”https://newsfilter.io/latest/fda-approvals” with=”#example_1”]
